Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genome-wide CRISPR/Cas9 Screen Identifies Host Factors Essential for Influenza Virus Replication
Julianna Han, Jasmine T. Perez, Cindy Chen, et al.
Cell Reports (2018) Vol. 23, Iss. 2, pp. 596-607
Open Access | Times Cited: 228

Showing 1-25 of 228 citing articles:

The next generation of CRISPR–Cas technologies and applications
Adrian Pickar‐Oliver, Charles A. Gersbach
Nature Reviews Molecular Cell Biology (2019) Vol. 20, Iss. 8, pp. 490-507
Open Access | Times Cited: 1236
Global view of human protein glycosylation pathways and functions
Katrine T. Schjoldager, Yoshiki Narimatsu, Hiren J. Joshi, et al.
Nature Reviews Molecular Cell Biology (2020) Vol. 21, Iss. 12, pp. 729-749
Closed Access | Times Cited: 908
Bat-borne virus diversity, spillover and emergence
Michael Letko, Stephanie N. Seifert, Kevin J. Olival, et al.
Nature Reviews Microbiology (2020) Vol. 18, Iss. 8, pp. 461-471
Open Access | Times Cited: 438
Antibiotic Resistance: One Health One World Outlook
Bilal Aslam, Mohsin Khurshid, Muhammad Arshad, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 375
Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC
Lai Wei, Derek Lee, Cheuk‐Ting Law, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 331
Host-Directed Antiviral Therapy
Naveen Kumar, Shalini Sharma, Ram Kumar, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 3
Open Access | Times Cited: 187
Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection
Bo Li, Sara Clohisey, Bing Shao Chia, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 184
Host and viral determinants for efficient SARS-CoV-2 infection of the human lung
Hin Chu, Bingjie Hu, Xiner Huang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 140
Antiviral Approaches against Influenza Virus
Rashmi Kumari, Suresh D. Sharma, Amrita Kumar, et al.
Clinical Microbiology Reviews (2023) Vol. 36, Iss. 1
Open Access | Times Cited: 86
CRISPR/Cas9 systems: Delivery technologies and biomedical applications
Yimin Du, Yanfei Liu, Jiaxin Hu, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 6, pp. 100854-100854
Open Access | Times Cited: 47
Role of MAPK/MNK1 signaling in virus replication
Ram Kumar, Nitin Khandelwal, Thachamvally Riyesh, et al.
Virus Research (2018) Vol. 253, pp. 48-61
Open Access | Times Cited: 124
A humanized MDCK cell line for the efficient isolation and propagation of human influenza viruses
K. Takada, Chiharu Kawakami, Shufang Fan, et al.
Nature Microbiology (2019) Vol. 4, Iss. 8, pp. 1268-1273
Closed Access | Times Cited: 94
ANP32 Proteins Are Essential for Influenza Virus Replication in Human Cells
Ecco Staller, Carol Sheppard, Peter J. Neasham, et al.
Journal of Virology (2019) Vol. 93, Iss. 17
Open Access | Times Cited: 80
Guide RNA modification as a way to improve CRISPR/Cas9-based genome-editing systems
Julia A. Filippova, Anastasiya Matveeva, Evgenii Zhuravlev, et al.
Biochimie (2019) Vol. 167, pp. 49-60
Closed Access | Times Cited: 80
Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication
Santseharay Ramírez, Carlota Fernandez-Antunez, Andrea Galli, et al.
Antimicrobial Agents and Chemotherapy (2021) Vol. 65, Iss. 7
Open Access | Times Cited: 78
Genetic glycoengineering in mammalian cells
Yoshiki Narimatsu, Christian Büll, Yen‐Hsi Chen, et al.
Journal of Biological Chemistry (2021) Vol. 296, pp. 100448-100448
Open Access | Times Cited: 74
Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor
Oded Danziger, Roosheel S. Patel, Emma J. DeGrace, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 4, pp. e1010464-e1010464
Open Access | Times Cited: 47
Pathogen-driven CRISPR screens identify TREX1 as a regulator of DNA self-sensing during influenza virus infection
Cason R. King, Yiping Liu, Katherine A. Amato, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 9, pp. 1552-1567.e8
Open Access | Times Cited: 32
Influenza A virus exploits transferrin receptor recycling to enter host cells
Béryl Mazel‐Sanchez, Chengyue Niu, Nathalia Williams, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 21
Open Access | Times Cited: 27
SLC35A2 modulates paramyxovirus fusion events during infection
Yanling Yang, Yuchen Wang, Danielle E. Campbell, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012531-e1012531
Open Access | Times Cited: 1
Genome‐wide siRNA library screening identifies human host factors that influence the replication of the highly pathogenic H5N1 influenza virus
Guangwen Wang, Li Jiang, Jinliang Wang, et al.
mLife (2025) Vol. 4, Iss. 1, pp. 55-69
Open Access | Times Cited: 1
Cellular SLC35B4 promotes internalization during influenza A virus entry
Guangwen Wang, Li Jiang, Yan Ya, et al.
mBio (2025)
Open Access | Times Cited: 1
Carnosol inhibits influenza A virus by disrupting the viral envelope and interfering with Jak2/STAT3 signaling pathway
Lishan Sun, Yang Zhang, Can Xu, et al.
European Journal of Pharmacology (2025), pp. 177606-177606
Closed Access | Times Cited: 1
Influenza virus repurposes the antiviral protein IFIT2 to promote translation of viral mRNAs
Vy M. Tran, Mitchell P. Ledwith, Thiprampai Thamamongood, et al.
Nature Microbiology (2020) Vol. 5, Iss. 12, pp. 1490-1503
Open Access | Times Cited: 69
Applying genome-wide CRISPR-Cas9 screens for therapeutic discovery in facioscapulohumeral muscular dystrophy
Angela Lek, Tracy Zhang, Keryn G. Woodman, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 536
Open Access | Times Cited: 61
Page 1 - Next Page

Scroll to top